NYSE$AMWL
American Well Corp · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Revenue increased slightly, gross margins expanded, and visit volume decreased.
Amwell reported a slight increase in revenue and an expansion of gross margins, but experienced a decrease in total visits. The company is adjusting its visit forecast downwards due to the resurgence of mask mandates and other factors related to the COVID-Delta variant.
- Revenue increased 5% over last quarter to $60.2 million.
- Gross margins increased 600 bps to 44% of revenue versus 38% last quarter.
- Total visits decreased to 1.3 million compared to 1.6 million last quarter.
- The company is adjusting down its visit forecast for the remainder of the year.
Headline financials
Revenue & EPS history
American Well · Revenue · Quarterly
$60.2M
Revenue by segment
American Well · $54.3M total across 2 segments · Q2 2021
- AMG Visit Revenue$27.5M—50.6%
- Subscription Revenue$26.8M—49.4%
Forward guidance
For 2021, Amwell is adjusting their previous visits outlook to account for changes related to COVID-Delta variant and now expects revenue between $252 and $262 million and Adjusted EBITDA between ($154) and ($146) million.
Tailwinds
- Technology subscription revenues and services & care points revenues are confirmed as these businesses are operating at or above original forecast levels.
- Guidance adjusted solely for changes in visits outlook due to factors related to COVID-Delta variant, mainly flu season estimates.
- Acknowledges gross margin and operational efficiencies of $12 million netted against $10 million EBITDA burden from two acquisitions.
Headwinds
- Revenue between $252 and $262 million from the previous range of $260 to $270 million
- Narrowed and adjusted AMG visit volume to between 1.4 and 1.5 million from previous range of 1.5 to 1.7 million
- Adjusted EBITDA between ($154) and ($146) million from the previous range of ($157) and ($147) million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
+1.4%
Avg return
Earnings day
+2.1%
Avg return
5 days after
-2.2%
Avg return
30 days after
41%
9 / 22 earnings
Positive
+33.8%
Q2 2024
Best reaction
-20.9%
Q1 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.0% | +27.2% | +34.0% | |
| Q4 2025 | +24.7% | +34.9% | +29.8% | |
| Q3 2025 | -9.5% | -20.0% | -20.6% | |
| Q1 2025 | +19.7% | +9.5% | +8.9% | |
| Q4 2024 | -5.0% | -3.6% | -35.5% | |
| Q3 2024 | -5.0% | -5.4% | -0.7% | |
| Q2 2024 | +33.8% | +13.9% | -1.1% | |
| Q1 2024 | +2.0% | +11.4% | -16.3% | |
| Q4 2023 | +23.6% | +20.8% | -16.0% | |
| Q3 2023 | +14.5% | +4.3% | +11.1% | |
| Q2 2023 | -8.3% | -13.9% | -35.2% | |
| Q1 2023 | -3.9% | -2.9% | +17.9% | |
| Q4 2022 | -13.1% | -19.2% | -37.3% | |
| Q3 2022 | -2.2% | +14.9% | -8.3% | |
| Q2 2022 | +9.2% | +6.8% | -4.8% | |
| Q1 2022 | -10.8% | +8.8% | +37.6% | |
| Q4 2021 | +7.2% | +1.0% | -8.0% | |
| Q3 2021 | -7.4% | -3.7% | -29.7% | |
| Q2 2021 | +0.7% | -1.7% | +0.8% | |
| Q1 2021 | -20.9% | -5.7% | +9.5% | |
| Q4 2020 | -4.1% | -10.8% | -1.5% | |
| Q3 2020 | -11.9% | -19.8% | +17.1% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro